# Antidepressants During Pregnancy Not Linked to Autism, ADHD, Study Finds
A new study offers reassurance to pregnant people taking antidepressants. Researchers found no connection between prenatal antidepressant use and increased risk of autism or ADHD in children.
This research addresses a longstanding concern for many expectant parents. Untreated depression during pregnancy carries real risks, including poor nutrition, inadequate prenatal care, and increased stress on the developing baby. Yet many pregnant people worry that the medication itself poses harm.
The study examined large populations of children exposed to antidepressants in utero and compared their outcomes to unexposed children. Results showed no elevated risk for autism spectrum disorder or attention-deficit/hyperactivity disorder across various antidepressant classes.
This matters because depression affects roughly 15 percent of pregnant people. Untreated maternal depression itself has documented effects on child development and behavior. The medication decision becomes a balance between treating the mother's mental health and concerns about fetal exposure.
Dr. Jennifer Ashton and other maternal health experts emphasize that the risks of untreated depression often outweigh the minimal risks associated with antidepressant use during pregnancy. Selective serotonin reuptake inhibitors (SSRIs) like sertraline and paroxetine remain among the most studied medications in pregnancy.
Pregnant people taking antidepressants should never stop medication without medical guidance. Abruptly discontinuing treatment can trigger relapse. Instead, the American College of Obstetricians and Gynecologists recommends working with a healthcare provider to weigh individual benefits and risks.
Women planning pregnancy or currently pregnant who experience depression should discuss treatment options with their obstetrician or mental health provider. Many effective options exist, from medication to therapy, and the focus